Signed an LOI with Eye Care partner Covalent Medical - $63M over 5 years

Clearsight and Covalent Medical have signed an LOI for $63M over 5years. ClearSight will manufacture and produce 6 unique SKUs for Covalent Medical to commercialize and sell. The agreement will entail 3 products under the Focus Tears brand family (www.focusvitamins.com), which will be sold directly through Ophthalmologists and Optometrists to patients suffering from Dry Eye, Wearing contact lenses and Pink Eye. They will also launch 3 SKUs under a separate brand, Alivyo, for sale through the Retail Channel (CVS, Walgreens, etc.).